September 29, 2025

ATA Issues New Guidelines for Differentiated Thyroid Cancer

September 29, 2025 / Clinical Practice / InnovateMed Author / thyroid cancer

New guidelines from the American Thyroid Association (ATA) for managing adults with differentiated thyroid cancer (DTC) include several recommendations aimed at de-escalating treatment where possible, while also suggesting further work is needed to address financial toxicity of this disease. The guidelines, published in Thyroid in August, represent the first major update for the management of DTC in a decade. The […]

ATA Issues New Guidelines for Differentiated Thyroid Cancer Read More »

Can Patients Skip Fasting With Higher Levothyroxine Dose?

September 29, 2025 / Clinical Practice / InnovateMed Author / levothyroxine

SCOTTSDALE, AZ — Among patients with hypothyroidism, administering a higher dose of levothyroxine with breakfast preserved thyroid-stimulating hormone (TSH) stability and was favored by patients compared to taking the usual dose followed by a 1-hour fasting period, a new study has found. “A 15% dose-adjusted levothyroxine regimen taken with breakfast maintains TSH stability comparable to standard fasting levothyroxine in well-controlled

Can Patients Skip Fasting With Higher Levothyroxine Dose? Read More »

4 types of foods can boost happiness, well-being in aging adults

September 29, 2025 / Patient education / InnovateMed Author / happiness

What we eat could influence our psychological well-being as we age, research has shown. Rob and Julia Campbell/Stocksy There is ongoing research on how food relates to mental well-being and mental health conditions such as depression. An area of study is how foods impact aspects like happiness and life satisfaction. A recent study suggests that

4 types of foods can boost happiness, well-being in aging adults Read More »

The Glymphatic System: Not a Typo, the Brain’s Lymphatic System

September 29, 2025 / Clinical Practice / InnovateMed Author / glymphatic system

Dr Varga is a neurologist and sleep specialist at the Mount Sinai Integrative Sleep Center in New York. He attended the 2025 SLEEP meeting in Seattle, Washington, and he’s here to update us on the glymphatic system and why it’s important. Welcome, Dr Andrew Varga. Andrew W. Varga, MD, PhD: Thank you so much for having

The Glymphatic System: Not a Typo, the Brain’s Lymphatic System Read More »

Medtronic wins FDA approval for urinary incontinence device

September 29, 2025 / Research update / InnovateMed Author / urinary incontinence

Analysts said Altaviva is an attractive option compared to rival products, informing their belief that Medtronic can capitalize on a large market opportunity. Published Sept. 22, 2025 By Nick Paul Taylor Medtronic’s office in Santa Clara, California, on June 10, 2023. Alamy Dive Brief: Medtronic has received Food and Drug Administration approval for a neuromodulation therapy in urge

Medtronic wins FDA approval for urinary incontinence device Read More »

First Randomized Trial of Tirzepatide in T1D Shows Benefits

September 29, 2025 / Research update / InnovateMed Author / Tirzepatide

VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with type 1 diabetes (T1D). “Tirzepatide may play a role in weight management in adults with T1D and obesity, even at low doses,” Jennifer R. Snaith, MD, of the Garvan Institute of

First Randomized Trial of Tirzepatide in T1D Shows Benefits Read More »

Alopecia Areata: Complete Scalp Hair Regrowth Possible With JAK Inhibitor Treatment – pharmaceutical

September 29, 2025 / Research update / InnovateMed Author / alopecia

PARIS — Long-term results from the ALLEGRO clinical trial program of Pfizer’s JAK inhibitor ritlecitinib for severe alopecia areata showed that complete scalp regrowth occurred in a good proportion of patients. Nearly one third (31.2%) of patients taking ritlecitinib over 3 years had complete scalp hair regrowth at least once, Brett King, MD, PhD, a dermatologist based in Fairfield,

Alopecia Areata: Complete Scalp Hair Regrowth Possible With JAK Inhibitor Treatment – pharmaceutical Read More »

FDA approves Crinetics Pharmaceuticals’ first drug

September 29, 2025 / News update / InnovateMed Author / first drug

Crinetics Pharmaceuticals just won its first Food and Drug Administration approval with Palsonify, a once-daily pill for adults with acromegaly, a rare and debilitating hormonal disorder, who cannot undergo surgery or did not respond to it. Backed by two late-stage trials showing significant drops in growth hormone and improved symptoms, the small-molecule drug offers patients an oral

FDA approves Crinetics Pharmaceuticals’ first drug Read More »

How a single protein rewires leukemia cells to fuel their growth

September 29, 2025 / Research update / InnovateMed Author / leukemia

by University of California, Los Angeles edited by Robert Egan Editors’ notes Credit: Unsplash/CC0 Public Domain Cancer cells are relentless in their quest to grow and divide, often rewiring their metabolism and modifying RNA to stay one step ahead. Now, researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a single protein, IGF2BP3, that links

How a single protein rewires leukemia cells to fuel their growth Read More »